Last $1.41 USD
Change Today +0.02 / 1.44%
Volume 19.4K
ULUR On Other Exchanges
Symbol
Exchange
OTC US
Berlin
As of 3:49 PM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

uluru inc (ULUR) Snapshot

Open
$1.39
Previous Close
$1.39
Day High
$1.44
Day Low
$1.39
52 Week High
03/20/14 - $1.83
52 Week Low
05/13/13 - $0.25
Market Cap
33.3M
Average Volume 10 Days
50.0K
EPS TTM
$-0.21
Shares Outstanding
23.6M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for ULURU INC (ULUR)

Related News

No related news articles were found.

uluru inc (ULUR) Related Businessweek News

No Related Businessweek News Found

uluru inc (ULUR) Details

ULURU Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of wound care and mucoadhesive film products in the United States and internationally. The company develops its products based on patented Nanoflex and OraDisc drug delivery technologies. Its products include Altrazeal, a transforming powder dressing for the treatment of various wounds, such as partial thickness burns, donor sites, and abrasions, as well as surgical, trauma, and chronic wounds; Aphthasol for the treatment of canker sores; OraDisc A for the treatment of oral conditions, which rely upon the use of medications formulated as gels and pastes that are applied to lesions in the mouth; and OraDisc B, a mucoadhesive disc product for the treatment and management of oral pain. The company is based in Addison, Texas.

7 Employees
Last Reported Date: 03/31/14

uluru inc (ULUR) Top Compensated Officers

Chairman, Chief Executive Officer, President ...
Total Annual Compensation: --
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $200.0K
Vice President of Polymer Drug Delivery
Total Annual Compensation: $175.0K
Compensation as of Fiscal Year 2012.

uluru inc (ULUR) Key Developments

ULURU Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Audited Consolidated Earnings Results for the Year Ended December 31, 2013; Provides Earnings Guidance for 2014

ULURU Inc. announced unaudited consolidated earnings results for the fourth quarter and audited consolidated earnings results for the year ended December 31, 2013. For the quarter, the company reported total revenues of $129,060 against $165,456 a year ago. The decrease of approximately $36,000 in revenues from the fourth quarter of 2013 compared to the fourth quarter of 2012 was primarily due to a decrease of $59,000 in Altrazeal veterinary product sales. This decrease was partially offset by an increase of $20,000 in royalties associated with Altrazeal. Loss before income taxes was $858,270 against $978,069 a year ago. Net loss was $858,270 against $978,069 a year ago. Net loss allocable to common stockholders was $858,270 against $990,357 a year ago. Basic and diluted net loss per common share was $0.04 against $0.10 a year ago. Operating loss was $751,828 against $868,803 a year ago. For the year, the company reported total revenues of $370,568 against $370,594 a year ago. Loss before income taxes was $3,080,914 against $3,531,349 a year ago. Net loss was $3,080,914 against $3,531,349 a year ago. Net loss allocable to common stockholders was $3,111,150 against $3,578,805 a year ago. Basic and diluted net loss per common share was $0.21 against $0.42 a year ago. Operating loss was $2,647,698 against $3,264,820 a year ago. The company anticipates that its 2014 results will be in line with its prior expectations. The company has now financially structured the company to quickly eliminate operating losses as revenue base expands.

ULURU Inc., Q4 2013 Earnings Call, Apr 01, 2014

ULURU Inc., Q4 2013 Earnings Call, Apr 01, 2014

ULURU Inc. Announces Further Expansion of Altrazeal International Marketing and Distribution Network

ULURU Inc. announced a further expansion of the Altrazeal(R) international marketing and distribution network. An agreement has been signed granting the exclusive marketing and distribution rights for Altrazeal(R) in India.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ULUR:US $1.41 USD +0.02

ULUR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for ULUR.
View Industry Companies
 

Industry Analysis

ULUR

Industry Average

Valuation ULUR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 67.7x
Price/Book 15.1x
Price/Cash Flow NM Not Meaningful
TEV/Sales 85.4x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ULURU INC, please visit www.uluruinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.